Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
| Original language | English |
|---|---|
| Pages (from-to) | 208-213.e3 |
| Journal | Journal of Pediatrics |
| Volume | 243 |
| DOIs | |
| State | Published - Apr 2022 |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Inc.
Funding
A.H. is supported by a Sub-agreement from the Johns Hopkins University with funds provided by R61HD105591 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and the Office of the Director, National Institute of Health (OD). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the Office of the Director, National Institutes of Health (OD), the National Institutes of Health, the National Institute of Biomedical Imaging and Bioengineering, the National Heart, Lung, and Blood Institute, or the Johns Hopkins University. The authors declare no conflicts of interest. A.H. is supported by a Sub-agreement from the Johns Hopkins University with funds provided by R61HD105591 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and the Office of the Director, National Institute of Health (OD). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the Office of the Director, National Institutes of Health (OD), the National Institutes of Health, the National Institute of Biomedical Imaging and Bioengineering, the National Heart, Lung, and Blood Institute, or the Johns Hopkins University. The authors declare no conflicts of interest.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Heart, Lung, and Blood Institute (NHLBI) | |
| NIH Office of the Director | |
| National Institute of Biomedical Imaging and Bioengineering | |
| Office of the Director | |
| The Johns Hopkins University | R61HD105591 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development |
Keywords
- mRNA COVID-19 vaccine-associated myopericarditis
- outcomes
- survey
- variability
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health